Comera Life Sciences Holdings, Inc.
Symbol: CMRA
NASDAQ
0.02684
USDMarket price today
-0.0074
P/E Ratio
0.0000
PEG Ratio
0.83M
MRK Cap
- 0.00%
DIV Yield
Comera Life Sciences Holdings, Inc. (CMRA) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4.23 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0.63 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 3.98 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 1.08 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 9.93 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 1.84 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0.37 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 2.21 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 6.53 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 1.85 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0.17 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 5.52 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 18.92 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0.98 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 34.22 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 13622.31 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | -152.04 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -9017.78 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | -4474.58 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 12.14 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 2.02 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | -2.2 | 0.3 | -6.2 | 0 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -9.01 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0.1 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | -0.08 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 1 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 1.41 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0.29 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0.51 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | -0.4 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 1 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | -0.08 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | -6.66 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0.01 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | -28.66 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0.13 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 650 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | -644.28 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.85 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 28.57 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | -0.9 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 5.94 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 6.84 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | -6.66 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | -35.34 | -9.8 | -3.9 | -1.8 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0.26 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0.74 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 1.43 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 8.45 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 9.88 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 10.15 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0.1 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | -9.07 | - | - | - | |||
income-statement-row.row.operating-income | -9.15 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | -9.01 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 75.23 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | -84.25 | -24 | -5.3 | -2.1 |
Frequently Asked Question
What is Comera Life Sciences Holdings, Inc. (CMRA) total assets?
Comera Life Sciences Holdings, Inc. (CMRA) total assets is 3727113.000.
What is enterprise annual revenue?
The annual revenue is 451365.000.
What is firm profit margin?
Firm profit margin is 0.735.
What is company free cash flow?
The free cash flow is -1.529.
What is enterprise net profit margin?
The net profit margin is -84.219.
What is firm total revenue?
The total revenue is -9.143.
What is Comera Life Sciences Holdings, Inc. (CMRA) net profit (net income)?
The net profit (net income) is -24038181.000.
What is firm total debt?
The total debt is 775048.000.
What is operating expences number?
The operating expences are 12392727.000.
What is company cash figure?
Enretprise cash is 1767870.000.